BGNE - BeiGene Ltd Stock Trading

BeiGene Ltd.(NASDAQ: BGNE) stock trading, description, contact, officers and directors.

About BeiGene Ltd.

Not available

Stock Information

BeiGene Ltd. Company Name:

BGNE Stock Symbol:

NASDAQ Market:

Get BGNE Alerts

News, Short Squeeze, Breakout and More Instantly...

BGNE - China National Medical Products Administration Approves Tislelizumab in Combination with Chemotherapy in First-Line Advanced Squamous Non-Small Cell Lung Cancer

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that its anti-PD-1 antibody tislelizumab has received approval from the China National Medical Products Administr...
BGNE - BeiGene Announces Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab

Novartis to co-develop and commercialize tislelizumab in North America, Japan, EU, and six other European countries BeiGene to receive $650 million upfront payment and is eligible to receive up to $1.55 billion in potential regulatory and sales milestone payments plus royaltie...
BGNE - Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid Tumor Immuno-Oncology Therapeutics Based on Strand's Next-Generation, Multi-Functional mRNA Technology

Exclusive License Focused on China and Other Key Asia-Pacific Markets Strand Therapeutics, a privately held developer of next-generation, programmable mRNA therapeutics for cancer and other diseases, and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) today announced that they...